Milestone Pharmaceuticals (MIST) EPS (Basic) (2018 - 2022)
Milestone Pharmaceuticals (MIST) posted EPS (Basic) of -$0.35 for Q3 2022, up 11.02% on a QoQ basis from -$0.4 in Q2 2022, and down 4.9% year-over-year from -$0.37 in Q3 2021.
Milestone Pharmaceuticals (MIST) EPS (Basic) (2018 - 2022) Analysis & Trends
Milestone Pharmaceuticals' EPS (Basic) history runs 5 years deep, the most recent figure standing at -$0.35 for Q3 2022.
- Quarterly EPS (Basic) fell 4.9% year-over-year to -$0.35 in Q3 2022, while the trailing twelve-month figure through Jun 2023 was -$0.35 (up 69.11% YoY) and the FY2021 annual result came in at -$1.02, up 39.84% from the prior year.
- EPS (Basic) was -$0.35 for Q3 2022 at Milestone Pharmaceuticals, up from -$0.4 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.02 in Q2 2021 and bottomed at -$30.44 in Q4 2018.
- A 5-year average of -$5.7 and a median of -$0.53 in 2019 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2021 — EPS (Basic) soared 103.51% — and 2022, when it slumped 2251.35%.
- Milestone Pharmaceuticals' EPS (Basic) stood at -$30.44 in 2018, then soared by 96.19% to -$1.16 in 2019, then surged by 74.51% to -$0.3 in 2020, then sank by 36.67% to -$0.4 in 2021, then grew by 12.36% to -$0.35 in 2022.
- Business Quant data shows MIST's EPS (Basic) at -$0.35 in Q3 2022, -$0.4 in Q2 2022, and -$0.4 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -0.35 |
| Jun 30, 2022 | -0.40 |
| Dec 31, 2021 | -0.40 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | 0.02 |
| Mar 31, 2021 | -0.30 |
| Dec 31, 2020 | -0.30 |
| Sep 30, 2020 | -0.40 |
| Jun 30, 2020 | -0.53 |
| Mar 31, 2020 | -0.67 |
| Dec 31, 2019 | -1.16 |
| Sep 30, 2019 | -0.52 |
| Jun 30, 2019 | -1.04 |
| Mar 31, 2019 | -17.33 |
| Dec 31, 2018 | -30.44 |
| Sep 30, 2018 | -20.16 |
| Jun 30, 2018 | -12.71 |
| Mar 31, 2018 | -15.57 |